[1] |
Vincent A, Herman J, Schulick R, et al. Pancreatic cancer[J]. Lancet, 2011, 378(9791): 607-620.
|
[2] |
中国抗癌协会胰腺癌专业委员会. 胰腺癌综合诊治指南(2018版)[J]. 临床肝胆病杂志, 2018, 34(10): 2109-2120.
|
[3] |
Ren B, Cui M, Yang G, et al. Tumor microenvironment participates in metastasis of pancreatic cancer[J]. Mol Cancer, 2018, 17(1): 108.
|
[4] |
Suhail Y, Cain MP, Vanaja K, et al. Systems biology of cancer metastasis[J]. Cell Syst, 2019, 9(2): 109-127.
|
[5] |
Kristensen LS, Andersen MS, Stagsted LVW, et al. The biogenesis, biology and characterization of circular RNAs[J]. Nat Rev Genet, 2019, 20(11): 675-691.
|
[6] |
Wang Y, Liu J, Ma J, et al. Exosomal circRNAs: biogenesis, effect and application in human diseases[J]. Mol Cancer, 2019, 18(1): 116.
|
[7] |
Meng S, Zhou H, Feng Z, et al. CircRNA: functions and properties of a novel potential biomarker for cancer[J]. Mol Cancer, 2017, 16(1): 94.
|
[8] |
李玉婷,孔瑶,罗宇明, 等. 环状RNA-PCAC1促进胰腺导管腺癌侵袭转移的研究[J/CD]. 中华普通外科学文献(电子版), 2020, 14(3): 174-179.
|
[9] |
Chen LL. The expanding regulatory mechanisms and cellular functions of circular RNAs[J]. Nat Rev Mol Cell Biol, 2020, 21(8): 475-490.
|
[10] |
Zhang HD, Jiang LH, Sun DW, et al. CircRNA: A novel type of biomarker for cancer[J]. Breast Cancer, 2018, 25(1): 1-7.
|
[11] |
Weng W, Wei Q, Toden S, et al. Circular RNA ciRS-7-A promising prognostic biomarker and a potential therapeutic target in colorectal cancer[J]. Clin Cancer Res, 2017, 23(14): 3918-3928.
|
[12] |
李四桥,常清潭,刘海潮, 等. 环状RNA circ-MFN2在胰腺癌中的表达及其临床意义[J]. 中国普外基础与临床杂志, 2021, 28(6): 762-767.
|
[13] |
Kong Y, Li Y, Luo Y, et al. circNFIB1 inhibits lymphangiogenesis and lymphatic metastasis via the miR-486-5p/PIK3R1/VEGF-C axis in pancreatic cancer[J]. Mol Cancer, 2020, 19(1): 82.
|
[14] |
Wade M, Li YC, Wahl GM. MDM2, MDMX and p53 in oncogenesis and cancer therapy[J]. Nat Rev Cancer, 2013, 13(2): 83-96.
|
[15] |
Aubrey BJ, Strasser A, Kelly GL. Tumor-suppressor functions of the TP53 pathway[J]. Cold Spring Harb Perspect Med, 2016, 6(5): a026062.
|